RSKD RISKIFIED LTD. Insider Trading

RSKD Director Erez Shachar sold 302,657 shares for $1,587,859.99 via scheduled 10b5-1 plan

Erez Shachar (Director) executed two separate sales totaling 302,657 shares for $1,587,859.99 (blended average $5.25) on 2026-07-06 and 2026-07-07, reducing his holdings from 1,928,427 to 1,625,770 shares (-15.7%). This transaction is part of a pre-arranged 10b5-1 trading plan, meaning it was scheduled rather than a discretionary decision made in response to current market conditions. The current stock price of $5.19 is 8.6% below the 52-week high of $5.68, while the 90-day price change shows positive momentum (+30.7%). The insider retains 1.63M shares post-transaction, maintaining substantial holdings. The flagged 10b5-1 plan structure removes timing considerations from the analysis, as execution follows a predetermined schedule established earlier.

CTO Assaf Feldman sells 230,512 shares of RSKD at $5.02 under 10b5-1 plan adopted 2026-03-16

Assaf Feldman executed a sale of 230,512 shares at $5.02 on 2026-07-01 as part of a pre-arranged 10b5-1 trading plan adopted on 2026-03-16, reducing his holdings from 2,130,471 shares to 1,899,959 shares. The transaction is scheduled rather than discretionary, so it reflects predetermined execution rather than a market-timing decision. At the current price of $5.25, the stock has moved +10.5% over 30 days and +28.4% over 90 days, positioning the sale below recent momentum but within the 52-week range of $3.70–$5.68.

Director Erez Shachar sold 701,449 shares at $5.02-$5.08 (total $3,536,025.98); 2 sales via scheduled 10b5-1 plan

Erez Shachar executed two separate sales totaling 701,449 shares for $3,536,025.98 on July 1–2, 2026, reducing his holdings by -26.7% from 2,629,876 to 1,928,427 shares. This is a scheduled transaction under a 10b5-1 trading plan, not a discretionary decision. The sales occurred against a backdrop of recent price strength: the stock is at $5.25 (current), up 10.5% over 30 days and 28.4% over 90 days, trading -7.6% from its 52-week high of $5.68. The sales price ($5.04 blended average) sits within the 52-week range of $3.70–$5.68. Notably, Shachar executed five separate sales at this ticker between June 16–24, 2026 (all also showing outcomes not yet measurable), suggesting a pattern of pre-scheduled liquidation occurring before this filing. Cross-ticker, his 13 prior open-market sells averaged a 30-day return of +5.1%, though same-ticker outcome measurement remains pending for all prior trades at RSKD.

Director Erez Shachar sells 502,101 shares for $2,527,102.76 via 10b5-1 plan at RSKD

Director Erez Shachar executed 2 separate sales totaling 502,101 shares for $2,527,102.76, reducing his holdings by 16.0% from 3,131,977 shares to 2,629,876 shares. The sales occurred at prices of $5.05 and $5.02 on consecutive trading days, with a blended average of $5.03, compared to the current price of $5.02. This transaction is part of a pre-arranged 10b5-1 trading plan, indicating the sales were scheduled rather than discretionary. Shachar's cross-ticker track record shows 13 prior open-market sales with an average 30-day return of +5.1%, though his prior same-ticker sales at RSKD have outcomes not yet measurable. The filing reflects a substantial reduction in a director's stake executed through a plan framework that eliminates timing-based inference.

Director Erez Shachar sold 480,085 shares (~$2.4M) across 2 transactions via 10b5-1 plan

Erez Shachar, a Director at Riskified Ltd., executed 2 separate sales totaling 480,085 shares for $2,400,968.82 on June 25–26, 2026, at a blended average price of $5.00. This represents a reduction of 13.3% of his pre-transaction holdings (from 3,612,062 shares to 3,131,977 shares post-transaction). The sales were executed under a 10b5-1 trading plan, meaning they were scheduled in advance rather than discretionary decisions. His cross-ticker track record shows 13 prior sales with an average 30-day return of +5.1%, though same-ticker outcomes at RSKD are not yet measurable from these recent June trades. The current stock price is $5.02, placing the transaction prices near current levels and the stock within 11.6% of its 52-week high.

Director Erez Shachar sold 318,500 shares at blended $4.91 (2 sales, $1.6M total) via 10b5-1 plan at RSKD

Erez Shachar completed two separate sales totaling 318,500 shares for $1,563,534.00 on June 23–24, 2026, executing sales at $4.93 and $4.89 respectively. This transaction is part of a pre-arranged 10b5-1 trading plan, meaning it was scheduled rather than discretionary. The director retains 3,612,062 shares post-transaction, representing an -8.1% reduction in holdings. The stock is trading at $4.90, approximately -13.7% from its 52-week high of $5.68, while the 90-day change shows +29.3%. Notably, Shachar has initiated five separate sales at RSKD within the past three weeks (June 2, 8, 9, 12, and 15), though none have measurable outcomes yet, indicating a systematic reduction in his position under the scheduled plan.

Director Erez Shachar sells 357,559 shares (8.0% of holdings) at $4.95 average; scheduled 10b5-1 plan, frequent recent activity.

Erez Shachar, as Director of Riskified Ltd., executed 3 separate sales totaling 357,559 shares for $1,769,084.11 across June 16–17, 2026, at a blended average price of $4.95, reducing his post-transaction holdings to 4,107,366 shares. The transaction is governed by a 10b5-1 trading plan adopted on 2026-03-16, making this a scheduled, not discretionary, transaction. The timing cannot be assessed against market conditions, as the plan was pre-arranged. However, the frequency pattern is notable: this represents the sixth recorded sale at RSKD within a 14-day window (June 2–16), reflecting systematic execution of the established plan. The current price of $4.95 matches the blended transaction average, placing the sales within recent trading range activity without obvious price deviation.

Director Erez Shachar sold 231,124 shares at $4.96 avg in 2 transactions for $1,147,415.48

Erez Shachar sold 231,124 shares across 2 transactions on 2026-06-12 and 2026-06-15 at blended average price $4.96, totaling $1,147,415.48, reducing holdings by 4.9%. At the current price of $4.96, the stock is -12.7% from its 52-week high of $5.68 and has gained 7.6% over 30 days and 15.1% over 90 days. His same-ticker history at RSKD shows 4 prior sales with mixed near-term results, with only 1 of 4 prior trades well-timed at the 90-day mark, suggesting inconsistent execution timing on this ticker specifically.

Director Erez Shachar sells 240,612 shares at $4.87–$4.90 for $1.2M; retains 4.39M shares at RSKD.

Erez Shachar executed 2 separate sales totaling 240,612 shares for $1,176,730.25 on consecutive trading days, reducing his RSKD stake by 5.2% from 4.63M to 4.39M shares. The sales occurred at an average price of $4.89, trading 1–5 cents above the current price of $4.84, within the 52-week range of $3.70–$5.68. At his prior 4 RSKD trades, Shachar achieved poor timing: only 1 of 4 prior sales was well-timed at the 90-day mark, and two recent 2026 sales posted slightly negative or flat 90-day returns (-0.7% and +0.3%), suggesting modest historical predictive value at this ticker. The lack of transaction FLAGS prevents timing characterization, but the pattern of frequent sales at this stock in late May and early June, combined with modest historical returns on similar transactions, offers limited signal of conviction or concern at current price levels.

Director Erez Shachar sold 201,796 shares across 2 transactions for $1,003,459.63 at RSKD

Erez Shachar, a director at Riskified, executed 2 separate sales totaling 201,796 shares on June 1-2, 2026, at an average price of $4.97, generating proceeds of $1,003,459.63. The sales reduced his holdings from 4,876,326 shares to 4,674,530 shares, representing a -4.1% reduction in his position. At the current price of $4.80, the stock trades -15.5% from its 52-week high of $5.68, and the insider's transaction prices of $4.97 and $4.94 were executed near recent lows within the 52-week range of $3.70–$5.68. This multi-transaction sale by a director warrants attention to verify whether it reflects operational liquidity needs or portfolio rebalancing versus any underlying business concern.